Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Feige

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Veterinary Pathology|May 29, 2015
Generalized Degenerative Joint Disease in Osteoprotegerin (Opg) Null Mutant MiceB Bolon, M Grisanti, K Villasenor, et al.
Cellular and Molecular Life Sciences : CMLS|November 15, 2000
Anti-interleukin-1 and anti-tumor necrosis factor-alpha synergistically inhibit adjuvant arthritis in Lewis ratsU Feige, Y L Hu, J Gasser, et al.
Rheumatology International|January 1, 1989
Differential immunological response of patients with rheumatoid arthritis towards two different Epstein-Barr virus strains: inhibition of interleukin-1 release by the B95-8, but not the P3HR-1 virus strainT Häupl, G R Burmester, G Hahn, et al.
Diabetologia|July 25, 2003
Prevention of primary non-function of islet xenografts in autoimmune diabetic NOD mice by anti-inflammatory agentsC Gysemans, K Stoffels, A Giulietti, et al.
Annals of the Rheumatic Diseases|March 19, 2009
Anti-inflammatory and cartilage-protecting effects of an intra-articularly injected anti-TNF{alpha} single-chain Fv antibody (ESBA105) designed for local therapeutic useD M Urech, U Feige, S Ewert, et al.
Protein Engineering|May 1, 1994
A mutational analysis of receptor binding sites of interleukin-1 beta: differences in binding of human interleukin-1 beta muteins to human and mouse receptorsM G Grütter, J van Oostrum, J P Priestle, et al.
Drugs Under Experimental and Clinical Research|January 1, 1989
An assay for the detection of interleukin-1 synthesis inhibitors: effects of antirheumatic drugsC Rordorf-Adam, J Lazdins, K Woods-Cook, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|October 20, 2001
Development of a novel, nonimmunogenic, soluble human TNF receptor type I (sTNFR-I) construct in the baboonJ J Rosenberg, S W Martin, J E Seely, et al.
Nature|December 2, 1999
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligandY Y Kong, U Feige, I Sarosi, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Veterinary Pathology|May 29, 2015
Generalized Degenerative Joint Disease in Osteoprotegerin (Opg) Null Mutant MiceB Bolon, M Grisanti, K Villasenor, et al.
Cellular and Molecular Life Sciences : CMLS|November 15, 2000
Anti-interleukin-1 and anti-tumor necrosis factor-alpha synergistically inhibit adjuvant arthritis in Lewis ratsU Feige, Y L Hu, J Gasser, et al.
Rheumatology International|January 1, 1989
Differential immunological response of patients with rheumatoid arthritis towards two different Epstein-Barr virus strains: inhibition of interleukin-1 release by the B95-8, but not the P3HR-1 virus strainT Häupl, G R Burmester, G Hahn, et al.
Diabetologia|July 25, 2003
Prevention of primary non-function of islet xenografts in autoimmune diabetic NOD mice by anti-inflammatory agentsC Gysemans, K Stoffels, A Giulietti, et al.
Annals of the Rheumatic Diseases|March 19, 2009
Anti-inflammatory and cartilage-protecting effects of an intra-articularly injected anti-TNF{alpha} single-chain Fv antibody (ESBA105) designed for local therapeutic useD M Urech, U Feige, S Ewert, et al.
Protein Engineering|May 1, 1994
A mutational analysis of receptor binding sites of interleukin-1 beta: differences in binding of human interleukin-1 beta muteins to human and mouse receptorsM G Grütter, J van Oostrum, J P Priestle, et al.
Drugs Under Experimental and Clinical Research|January 1, 1989
An assay for the detection of interleukin-1 synthesis inhibitors: effects of antirheumatic drugsC Rordorf-Adam, J Lazdins, K Woods-Cook, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|October 20, 2001
Development of a novel, nonimmunogenic, soluble human TNF receptor type I (sTNFR-I) construct in the baboonJ J Rosenberg, S W Martin, J E Seely, et al.
Nature|December 2, 1999
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligandY Y Kong, U Feige, I Sarosi, et al.
Pageof 4